Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Assembly Biosciences Inc

ASMB ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Biotechnology & Medical Research ·

USA Small Cap Analyst: STRONG BUY

Last Close

$32.95

▲ +10.02%

Market Cap $670.88M · Vol 188.51K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$670.88M

Small Cap

Div Yield

N/A

EPS Growth

-368.18%

YoY

RSI (14)

81.63

Momentum

Beta

1.16

vs Market

52W High

$39.64

16.87% below

52W Low

$20.27

62.56% above

Volume

188.51K

Avg 54.77K

P/B

2.61

Price-to-book

ROE

N/A

Return on equity

Free Float

71.51%

Public shares

Shariah Compliance8 STANDARDS

✗ Assembly Biosciences Inc (ASMB) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does ASMB pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+23.50%

+23.13%

+8.75%

+23.59%

YTD

-3.12%

+32.01%

+177.50%

-23.30%

Financials & Valuation

TTM · Annual

Total Revenue	$72.30M
Net Income	$-6,122,000.00
Revenue Growth (YoY)	+38.94%
Gross Margin	100.00%
Operating Margin	-16.76%
Net Profit Margin	-8.47%
ROE	N/A
ROA · ROIC	-3.25% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	5.27
P/B	2.61
P/FCF	N/A
EPS Growth	-368.18%
Outstanding Shares	20.36M

Technical Indicators

50-Day SMA	$25.98
200-Day SMA	$29.17
RSI (14)	81.63
Beta	1.16
52-Week High	$39.64
52-Week Low	$20.27

Volume Today	188.51K
Avg Daily Volume (30D)	54.77K
Relative Volume	3.44x
Volatility (10D)	60.02
Volatility (30D)	57.05
Free Float	71.51%

Analyst Consensus

STRONG BUY

Current Price $32.95

Mean Target $50.00

52W Low$20.27 52W High$39.64

Current

Target

$20.27 $39.64

Current Analyst target

+51.75% upside potential · 4 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001T9BMW0

ISINUS0453962070

CountryUnited States of America

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateNov 8, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -1.78% RVMD Revolution Medicines Inc +0.85% ONC BeOne Medicines AG -2.40% 068270.KS Celltrion Inc -0.50% ABVX Abivax SA -2.05%

Company Profile

Assembly Biosciences, Inc. is a biotechnology company, which is engaged in the development of small-molecule therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. Its pipeline includes multiple clinical-stage investigational therapies, including two helicase-primase inhibitors (HPI) targeting recurrent genital herpes; an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, and a potent next-generation capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. Its pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) targeting transplant-related herpesviruses, which is undergoing studies to enable a regulatory filing, and it also has additional research programs against multiple antiviral targets. It is advancing two investigational long-acting HPI candidates, ABI-5366 (5366) and (2) ABI-1179 (1179).